Ligand validation:5JJN

RET: RETINAL

RET is a Ligand Of Interest in 5JJN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5JJN_RET_A_310	63%	0%	0.153	0.95	7.02	3.8	10	18	8	0	100%	1
5JJN_RET_C_307	50%	0%	0.184	0.934	6.96	3.9	10	18	7	0	100%	1
9H1W_RET_A_301	89%	72%	0.063	0.942	0.76	0.35	1	-	8	0	100%	1
3QAP_RET_A_240	84%	9%	0.097	0.966	2.61	1.82	13	9	5	0	95%	1
9H20_RET_A_301	82%	72%	0.076	0.93	0.76	0.35	1	-	8	0	100%	1
4GYC_RET_A_301	77%	13%	0.121	0.96	2.08	1.93	6	7	5	0	100%	1
1H68_RET_A_300	71%	31%	0.139	0.96	1.61	1.14	4	4	2	0	100%	1
4OV0_RET_A_301	100%	8%	0.027	0.992	0.76	3.77	-	15	8	0	100%	1
9F9J_RET_A_317	100%	71%	0.026	0.991	0.7	0.44	1	-	5	0	100%	1
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	1
7XJC_RET_A_301	100%	10%	0.028	0.992	1.93	2.43	2	14	2	0	100%	0.5
7XJD_RET_A_301	100%	10%	0.029	0.991	1.93	2.42	2	14	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.